SCHEMBL2297589

SCHEMBL2297589

CCSc1cccc(-c2ccccc2)n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 3/20 0.64
HTR1A P08908 1/20 0.64
DRD2 P14416 1/20 0.64
HTR2A P28223 1/20 0.64
RAB9A P51151 4/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
SQOR Q9Y6N5 1/20 0.48
ASIC3 Q9UHC3 1/20 0.46
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
ALDH1A1 P00352 5/20 0.42
HTT P42858 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
NPC1 O15118 3/20 0.41
LMNA P02545 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28270672 0.80 HTR7 (0.41) HTR7HTR1ADRD2HTR2ARAB9A
SCHEMBL12796678 0.79 HTR7 (0.65) HTR7HTR1ADRD2HTR2ARAB9A
SCHEMBL27735646 0.79 MEN1 (0.60) HTR7HTR1ADRD2HTR2ARAB9A
SCHEMBL2469726 0.78 HTR7 (1.00) HTR7HTR1ADRD2HTR2ARAB9A
SCHEMBL9399130 0.75 HSD17B10 (0.52) HTR7HTR1ADRD2HTR2ARAB9A
SCHEMBL2666265 0.72 CCR1 (0.44) HTR7HTR1ADRD2HTR2ARAB9A
SCHEMBL58442 0.72 MEN1 (1.00) HTR7HTR1ADRD2HTR2ARAB9A
SCHEMBL9488790 0.72 KDM4E (0.47) RAB9ASQORALDH1A1HTTTDP1
SCHEMBL12427064 0.71 SQOR (0.52) HTR7HTR1ADRD2HTR2ARAB9A
SCHEMBL3922796 0.71 NOS3 (0.45) HTR7HTR1ADRD2HTR2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461183-B2 PPAR agonist compounds, preparation and uses GENFIT (FR) 2013-06-11 US disclosed
US-20110195993-A1 PPAR AGONIST COMPOUNDS, PREPARATION AND USES GENFIT (FR) 2011-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195993-A1 PPAR AGONIST COMPOUNDS, PREPARATION AND USES PPARD, PPARA, PPARG HTR7 625/4885HTR1A 789/4885DRD2 1365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.